These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16432015)

  • 21. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.
    DeWolfe D; Gandhi J; Mackenzie MR; Broge TA; Bord E; Babwah A; Mandelbrot DA; Pavlakis M; Cardarelli F; Viscidi R; Chandraker A; Tan CS
    PLoS One; 2017; 12(5):e0177339. PubMed ID: 28562595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients.
    Toyoda M; Puliyanda DP; Amet N; Baden L; Cam V; Radha R; Pao A; Vo A; Bunnapradist S; Moudgil A; Jordan SC
    Transplantation; 2005 Jul; 80(2):198-205. PubMed ID: 16041264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noncoding Control Region Pattern of BK polyomavirus in Kidney Transplant Patients With Nephropathy.
    Emami A; Yaghobi R; Moattari A; Baseri Salehi M; Roozbeh J
    Exp Clin Transplant; 2017 Apr; 15(2):150-156. PubMed ID: 26517063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence and regression of BK polyomavirus associated carcinoma: a clinical and next-generation sequencing study.
    Fu F; Deng W; Yu S; Liu Y; Yu L; Liu R; Lang J; Geng D; Geng J; Li J; Huang G; Luo M; Xiong F; Wu CL; Miao Y
    Clin Sci (Lond); 2018 Aug; 132(16):1753-1763. PubMed ID: 30026258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.
    Peretti A; Geoghegan EM; Pastrana DV; Smola S; Feld P; Sauter M; Lohse S; Ramesh M; Lim ES; Wang D; Borgogna C; FitzGerald PC; Bliskovsky V; Starrett GJ; Law EK; Harris RS; Killian JK; Zhu J; Pineda M; Meltzer PS; Boldorini R; Gariglio M; Buck CB
    Cell Host Microbe; 2018 May; 23(5):628-635.e7. PubMed ID: 29746834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Presumed Polyomavirus Viroporin VP4 of Simian Virus 40 or Human BK Polyomavirus Is Not Required for Viral Progeny Release.
    Henriksen S; Hansen T; Bruun JA; Rinaldo CH
    J Virol; 2016 Nov; 90(22):10398-10413. PubMed ID: 27630227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BKTyper: Free Online Tool for Polyoma BK Virus VP1 and NCCR Typing.
    Martí-Carreras J; Mineeva-Sangwo O; Topalis D; Snoeck R; Andrei G; Maes P
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early BK polyomavirus (BKV) reactivation in donor kidney is a risk factor for development of BKV-associated nephropathy.
    Saundh BK; Baker R; Harris M; Welberry Smith MP; Cherukuri A; Hale A
    J Infect Dis; 2013 Jan; 207(1):137-41. PubMed ID: 23100561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy.
    Nickeleit V; Klimkait T; Binet IF; Dalquen P; Del Zenero V; Thiel G; Mihatsch MJ; Hirsch HH
    N Engl J Med; 2000 May; 342(18):1309-15. PubMed ID: 10793163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
    Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
    Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of laboratory developed real-time PCR assays and RealStar(®) BKV PCR Kit for quantitative detection of BK polyomavirus.
    Hasan MR; Tan R; Al-Rawahi G; Thomas E; Tilley P
    J Virol Methods; 2016 Aug; 234():80-6. PubMed ID: 27091098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
    Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
    J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MICA Mutant A5.1 Influences BK Polyomavirus Reactivation and Associated Nephropathy After Kidney Transplantation.
    Tonnerre P; Gérard N; Gavlovsky PJ; Mazalrey S; Hourmant M; Cheneau ML; Cesbron-Gautier A; Renaudin K; Bressollette-Bodin C; Charreau B
    J Infect Dis; 2016 Sep; 214(5):807-16. PubMed ID: 27130430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BK polyomavirus genotypes Ia and Ib1 exhibit different biological properties in renal transplant recipients.
    Varella RB; Zalona ACJ; Diaz NC; Zalis MG; Santoro-Lopes G
    Virus Res; 2018 Jan; 243():65-68. PubMed ID: 29106916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review.
    Demey B; Tinez C; François C; Helle F; Choukroun G; Duverlie G; Castelain S; Brochot E
    J Clin Virol; 2018 Dec; 109():6-12. PubMed ID: 30343190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.
    Korth J; Widera M; Dolff S; Guberina H; Bienholz A; Brinkhoff A; Anastasiou OE; Kribben A; Dittmer U; Verheyen J; Wilde B; Witzke O
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29156086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.